Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NexGenix Pharmaceuticals

2003 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$120K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of therapies for oncology and nervous system diseases. The company develops a non-surgical intralesional treatment for dermal neurofibromas.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 1110 Park Avenue
  • Second Floor
  • New York, NY 10128
  • United States

+1 (212) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NexGenix Pharmaceuticals’s full profile, request a free trial.

NexGenix Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 23-Oct-2009 $120K 00.00 Completed
3. Later Stage VC (Series B) 16-Jul-2007 00.00 00.00 Completed Generating Revenue
2. Early Stage VC (Series A) Completed
1. Seed Round Completed
To view this company’s complete deal history including valuation and funding, request access »

NexGenix Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Lord Rothschild Angel (individual) Minority 000 0000 000000 0